BIOECLIPSE Trademark

Trademark Overview

On Tuesday, April 4, 2017, a trademark application was filed for BIOECLIPSE with the United States Patent and Trademark Office. The USPTO has given the BIOECLIPSE trademark a serial number of 87398361. The federal status of this trademark filing is REGISTERED as of Tuesday, May 4, 2021. This trademark is owned by ConcentRx, Inc.. The BIOECLIPSE trademark is filed in the Pharmaceutical Products category with the following description:

Immunotherapies for the treatment of cancer; pharmaceuticals for the treatment of cancer
bioeclipse

General Information

Serial Number87398361
Word MarkBIOECLIPSE
Filing DateTuesday, April 4, 2017
Status700 - REGISTERED
Status DateTuesday, May 4, 2021
Registration Number6341819
Registration DateTuesday, May 4, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2017

Trademark Statements

Goods and ServicesImmunotherapies for the treatment of cancer; pharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 10, 2017
Primary Code005
First Use Anywhere DateTuesday, September 29, 2020
First Use In Commerce DateTuesday, September 29, 2020

Trademark Owner History

Party NameBIOECLIPSE THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMOUNTAIN VIEW, CA 94043
Party NameBIOECLIPSE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressMOUNTAIN VIEW, CA 94043
Party NameConcentRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043
Party NameConcentRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMilpitas, CA 95035

Trademark Events

Event DateEvent Description
Friday, January 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, January 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 4, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 30, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, March 27, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, March 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, March 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 21, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, October 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 9, 2020NON-FINAL ACTION E-MAILED
Friday, October 9, 2020SU - NON-FINAL ACTION - WRITTEN
Thursday, October 8, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, October 5, 2020USE AMENDMENT FILED
Monday, October 5, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, April 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 3, 2020SOU EXTENSION 5 GRANTED
Wednesday, April 1, 2020SOU EXTENSION 5 FILED
Friday, April 3, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 1, 2020SOU TEAS EXTENSION RECEIVED
Saturday, October 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2019SOU EXTENSION 4 GRANTED
Thursday, October 3, 2019SOU EXTENSION 4 FILED
Thursday, October 3, 2019SOU TEAS EXTENSION RECEIVED
Thursday, April 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2019SOU EXTENSION 3 GRANTED
Tuesday, April 2, 2019SOU EXTENSION 3 FILED
Tuesday, April 2, 2019SOU TEAS EXTENSION RECEIVED
Friday, October 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 3, 2018SOU EXTENSION 2 GRANTED
Wednesday, October 3, 2018SOU EXTENSION 2 FILED
Wednesday, October 3, 2018SOU TEAS EXTENSION RECEIVED
Friday, February 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 7, 2018SOU EXTENSION 1 GRANTED
Wednesday, February 7, 2018SOU EXTENSION 1 FILED
Wednesday, February 7, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, October 3, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 8, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 8, 2017PUBLISHED FOR OPPOSITION
Wednesday, July 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 26, 2017ASSIGNED TO EXAMINER
Monday, April 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 7, 2017NEW APPLICATION ENTERED

Related Keywords

bioeclipse cancer treatment pharmaceuticals immunotherapies